Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery

Background In patients with gastric outlet obstruction (GOO) caused by gastric cancer, choosing between self-expandable metal stent (SEMS) placement and gastrojejunostomy (GJJ) is of concern, especially in those with good performance status. Objective To compare SEMS placement and GJJ. Design Retros...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastrointestinal endoscopy 2013-07, Vol.78 (1), p.55-62
Hauptverfasser: No, Jin Hee, MD, Kim, Sang Woo, MD, PhD, Lim, Chul-Hyun, MD, Kim, Jin Su, MD, Cho, Yu Kyung, MD, PhD, Park, Jae Myung, MD, PhD, Lee, In Seok, MD, PhD, Choi, Myung-Gyu, MD, PhD, Choi, Kyu Yong, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background In patients with gastric outlet obstruction (GOO) caused by gastric cancer, choosing between self-expandable metal stent (SEMS) placement and gastrojejunostomy (GJJ) is of concern, especially in those with good performance status. Objective To compare SEMS placement and GJJ. Design Retrospective study. Setting Single tertiary referral center. Patients Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 who had GOO caused by unresectable gastric cancer. Interventions SEMS placement and GJJ. Main Outcome Measurements Success rate, adverse events, patency, and survival duration. Results Of the 113 patients in this study, 72 underwent SEMS placement and 41 underwent GJJ. The 2 groups did not differ in the technical and clinical success and incidence of early adverse events. However, the rate of late adverse events was significantly higher in the SEMS group (44.4% vs 12.2%; P < .001). The median patency duration was shorter after SEMS placement than after GJJ (125 days vs 282 days; P = .001), even after additional SEMS placement (210 days vs 282 days; P = .044). The median survival was also significantly shorter after SEMS placement than after GJJ (189 days vs 293 days; P = .003). Survival differed between treatments in patients with ECOG 0-1 ( P = .006) but not in those with an ECOG performance status of 2 ( P = .208). Limitations Retrospective and single-center study. Conclusions GJJ is preferable to SEMS placement for the palliation of GOO caused by unresectable or metastatic gastric cancer in patients with a good performance status, especially ECOG 0-1.
ISSN:0016-5107
1097-6779
DOI:10.1016/j.gie.2013.01.041